Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 1769 Records) |
Query Trace: Breast Neoplasms and BRCA2[original query] |
---|
Phenotypes of carriers of two mutated alleles in major cancer susceptibility genes. Breast cancer research and treatment 2024 8 . Yael Laitman, Anni Niskakoski, Rinal Bernstein-Molho, Lotta Koskinen, Daniel Rabina, Juha Koskenvuo, Eitan Friedm |
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance. Molecular cancer 2024 8 23 (1): 158. Ksenija Nesic, John J Krais, Yifan Wang, Cassandra J Vandenberg, Pooja Patel, Kathy Q Cai, Tanya Kwan, Elizabeth Lieschke, Gwo-Yaw Ho, Holly E Barker, Justin Bedo, Silvia Casadei, Andrew Farrell, Marc Radke, Kristy Shield-Artin, Jocelyn S Penington, Franziska Geissler, Elizabeth Kyran, Robert Betsch, Lijun Xu, Fan Zhang, Alexander Dobrovic, Inger Olesen, Rebecca Kristeleit, Amit Oza, Iain McNeish, Gayanie Ratnayake, Nadia Traficante, , Anna DeFazio, David D L Bowtell, Thomas C Harding, Kevin Lin, Elizabeth M Swisher, Olga Kondrashova, Clare L Scott, Neil Johnson, Matthew J Wakefie |
Hypermethylation of the BRCA2 gene promoter and its co-hypermethylation with the BRCA1 gene promoter in patients with breast cancer. Cancer biomarkers : section A of Disease markers 2024 8 . Liliia Fishchuk, Zoia Rossokha, Olga Lobanova, Valeriy Cheshuk, Roman Vereshchako, Viktoriia Vershyhora, Nataliia Medvedieva, Olha Dubitskaa, Natalia Goroven |
General analysis of breast cancer patients tested for BRCA mutations and evaluation of acute radiotherapy toxicity. Northern clinics of Istanbul 2024 8 11 (4): 302-308. Sule Karabulut Gul, Huseyin Tepetam, Berrin Benli Yavuz, Ozge Kandemir Gursel, Ayse Altinok, Irem Yuksel, Omar Alomari, Banu Atalar, Ilknur Bilkay Gork |
Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer. BMC cancer 2024 8 24 (1): 1000. Yasuharu Kawamoto, Takuo Yamai, Kenji Ikezawa, Yusuke Seiki, Ko Watsuji, Takeru Hirao, Makiko Urabe, Yugo Kai, Ryoji Takada, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Tazuko Inoue, Fumie Fujisawa, Kazuyoshi Ohka |
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients. Genes 2024 7 15 (7): . Stefania Stella, Silvia Rita Vitale, Michele Massimino, Federica Martorana, Irene Tornabene, Cristina Tomarchio, Melissa Drago, Giuliana Pavone, Cristina Gorgone, Chiara Barone, Sebastiano Bianca, Livia Manzel |
Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients. Cancers 2024 7 16 (14): . Ava Kwong, Cecilia Y S Ho, Chun-Hang Au, Edmond S K |
Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers. NPJ breast cancer 2024 7 10 (1): 63. Sara P Myers, Varadan Sevilimedu, Andrea V Barrio, Audree B Tadros, Anita Mamtani, Mark E Robson, Monica Morrow, Minna K L |
Genomic profiling and comparative analysis of male versus female metastatic breast cancer across subtypes. Breast cancer research : BCR 2024 7 26 (1): 118. Arun Kadamkulam Syriac, Nitish Singh Nandu, Allison Clark, Mehrad Tavallai, Dexter X Jin, Ethan Sokol, Kimberly McGregor, Jeffrey S Ross, Natalie Danziger, Jose Pablo Leo |
Somatic and germline aberrations in homologous recombination repair genes among Chinese high-risk breast cancer patients by multi-gene next-generation sequencing. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 7 . Ling Xie, Jie Chen, YanYing Zheng, Yi Sun, Xiang Zhang, LeLe Chu, YiFen Zha |
The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation. Journal of gynecologic oncology 2024 7 . Yeon Jee Lee, Ji Hyun Kim, Youn Jee Kim, Yoon Jung Chang, Sun-Young Kong, Chong Woo Yoo, Dong Ock Lee, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park, Myong Cheol L |
[Examination of breast density in breast cancer discordant twin pairs]. Magyar onkologia 2024 7 68 (2): 171-176. Szilárd Veres, Fruzsina Martinovszky, Márk Di Giovanni, Bettina Budai, Beatrix Beszedics, István Szabó, Henriett Butz, Attila Patócs, Bálint Török, Mátyás Ujlaki, László Dávid Tárnoki, Domonkos Ádám Tárno |
Genomic Alterations Correlated to Trastuzumab Resistance and Clinical Outcomes in HER2+/HR- Breast Cancers of Patients Living in Northwestern China. Journal of Cancer 2024 7 15 (14): 4467-4476. Gang Ma, Binliang Huo, Yanwei Shen, Xulong Zhu, Chong Cheng, Wensheng Li, Wei Cao, Jianhui |
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer. NPJ breast cancer 2024 7 10 (1): 57. Peter A Fasching, Chunling Hu, Steven N Hart, Matthias Ruebner, Eric C Polley, Rohan D Gnanaolivu, Andreas D Hartkopf, Hanna Huebner, Wolfgang Janni, Peyman Hadji, Hans Tesch, Sabrina Uhrig, Johannes Ettl, Michael P Lux, Diana Lüftner, Markus Wallwiener, Lena A Wurmthaler, Chloë Goossens, Volkmar Müller, Matthias W Beckmann, Alexander Hein, Daniel Anetsberger, Erik Belleville, Pauline Wimberger, Michael Untch, Arif B Ekici, Hans-Christian Kolberg, Arndt Hartmann, Florin-Andrei Taran, Tanja N Fehm, Diethelm Wallwiener, Sara Y Brucker, Andreas Schneeweiss, Lothar Häberle, Fergus J Cou |
Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing. Annals of oncology : official journal of the European Society for Medical Oncology 2024 7 . C F Rowlands, S Allen, J Balmaña, S M Domchek, D G Evans, H Hanson, N Hoogerbrugge, P A James, K Nathanson, M Robson, M Tischkowitz, W D Foulkes, C Turnbu |
Digenic Inheritance of Mutations in Homologous Recombination Genes in Cancer Patients. Journal of personalized medicine 2024 6 14 (6): . Maria Valeria Freire, Marie Martin, Karin Segers, Edith Sepulchre, Natacha Leroi, Jérôme Coupier, Hassan Rezaei Kalantari, Pascal Wolter, Joëlle Collignon, Marc Polus, Olivier Plomteux, Claire Josse, Vincent Bou |
BRCA1, BRCA2 and PALB2 mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer. Biomedicines 2024 6 12 (6): . Ina Shehaj, Slavomir Krajnak, Katrin Almstedt, Yaman Degirmenci, Sophia Herzog, Antje Lebrecht, Valerie Catherine Linz, Roxana Schwab, Kathrin Stewen, Walburgis Brenner, Annette Hasenburg, Marcus Schmidt, Anne-Sophie Heim |
Spectrum and characteristics of germline PALB2 pathogenic variants in 1556 early-onset breast cancer patients in China. Journal of cancer research and clinical oncology 2024 6 150 (6): 322. Jing Li, Peng He, Qindong Cai, Lili Chen, Yali Wang, Weifeng Cai, Yibin Qiu, Shunyi Liu, Wenhui Guo, Minyan Chen, Yuxiang Lin, Chuan Wang, Fangmeng |
Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants. Breast cancer research and treatment 2024 6 . Song Wen, Meng Zhang, Jiuan Chen, Li Hu, Jie Sun, Lu Yao, Ye Xu, Juan Zhang, Yuntao X |
Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patients. Human genomics 2024 6 18 (1): 68. Diana Carolina Sierra-Díaz, Adrien Morel, Dora Janeth Fonseca-Mendoza, Nora Contreras Bravo, Nicolas Molano-Gonzalez, Mariana Borras, Isabel Munevar, Mauricio Lema, Henry Idrobo, Daniela Trujillo, Norma Serrano, Ana Isabel Orduz, Diego Lopera, Jaime González, Gustavo Rojas, Paula Londono-De Los Ríos, Ray Manneh, Rodrigo Cabrera, Wilson Rubiano, Jairo de la Peña, María Catalina Quintero, William Mantilla, Carlos M Restre |
Fertility and Pregnancy-Related Issues in Young BRCA Carriers With Breast Cancer. Breast cancer : basic and clinical research 2024 6 18 11782234241261429. Isotta Martha Magaton, Luca Arecco, Elene Mariamidze, Kristina Jankovic, Mihaela Stana, Giulia Buzzatti, Lucia Trevisan, Graziana Scavone, Silvia Ottonello, Piero Fregatti, Claudia Massarotti, Michael von Wolff, Matteo Lamberti |
Assessment of genome mutation analysis for tumor-informed detection of circulating tumor DNA in patients with breast cancer. Clinica chimica acta; international journal of clinical chemistry 2024 6 561 119818. Mugip Rahaman Abdul Wahab, Thirunavukkarasu Palaniyandi, Swarnakala Thamada, Sandhiya Viswanathan, Gomathy Baskar, Hemapreethi Surendran, P Baraneedharan, J Kannan, Maddaly Ravi, Suba Rajinikanth, Mohamed A El-Tayeb, Shaban Sy |
Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status. Breast cancer (Tokyo, Japan) 2024 6 . Melinda L Telli, Jennifer K Litton, J Thaddeus Beck, Jason M Jones, Jay Andersen, Lida A Mina, Raymond Brig, Michael Danso, Yuan Yuan, William F Symmans, Julia F Hopkins, Lee A Albacker, Antonello Abbattista, Kay Noonan, Marielena Mata, A Douglas Laird, Joanne L Bl |
Identification of RAD17 as a candidate cancer predisposition gene in families with histories of pancreatic and breast cancers. BMC cancer 2024 6 24 (1): 723. Sofie Joris, Philippe Giron, Catharina Olsen, Sara Seneca, Alexander Gheldof, Shula Staessens, Rajendra Bahadur Shahi, Sylvia De Brakeleer, Erik Teugels, Jacques De Grève, Frederik J H |
Breast Cancer High-Penetrance Genes BRCA1 and BRCA2 Mutations Using Next-Generation Sequencing Among Iraqi Kurdish Women. Cureus 2024 6 16 (6): e62160. Ahmad N Hassan, Mustafa S Musta |
High Frequency of BRCA2 c.5576_5579del Carriers in Kakogawa, Japan. Cancer diagnosis & prognosis 2024 5 4 (3): 309-314. Haruna Nakamura, Sachiko Mizumoto, Hirokazu Tanino, Yui Niwa, Mitsutoshi Ogino, Yoko Sakoda, Kazuhiko Tsuchiya, Seishi Kono, Muneharu Konishi, Sayaka Ueno, Tomonari Kunihi |
Peripheral immunophenotyping reveals lymphocyte stimulation in healthy women living with hereditary breast and ovarian cancer syndrome. iScience 2024 5 27 (6): 109882. József Ágoston Balog, Klaudia Horti-Oravecz, Dorottya Kövesdi, Anikó Bozsik, Janos Papp, Henriett Butz, Attila Patócs, Gábor János Szebeni, Vince Kornél Grolmu |
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study. Cancer 2024 5 . Francesco Schettini, Eva Blondeaux, Chiara Molinelli, Raphaëlle Bas, Hee Jeong Kim, Antonio Di Meglio, Rinat Bernstein Molho, Sabine C Linn, Katarzyna Pogoda, Estela Carrasco, Kevin Punie, Elisa Agostinetto, Nerea Lopetegui-Lia, Kelly-Anne Phillips, Angela Toss, Christine Rousset-Jablonski, Marion Acheritogaray, Alberta Ferrari, Shani Paluch-Shimon, Robert Fruscio, Wanda Cui, Stephanie M Wong, Claudio Vernieri, Maria Vittoria Dieci, Alexios Matikas, Mariya Rozenblit, Cynthia Villarreal-Garza, Laura De Marchis, Fabio Puglisi, Leonor Vasconcelos de Matos, Monica Mariño, Luis Teixeira, Rossella Graffeo, Alessia Rognone, Alessandra Chirco, Nicoleta Antone, Yara Abdou, Maximilian Marhold, Ivana Božovi?-Spasojevi?, Alfonso Cortés Salgado, Luca Carmisciano, Marco Bruzzone, Giuseppe Curigliano, Aleix Prat, Matteo Lamberti |
Clinicopathological characteristics and BRCA1/BRCA2 pathogenic variants of patients with breast cancer. Polish journal of pathology : official journal of the Polish Society of Pathologists 2024 5 75 (1): 1-7. Nazan Eras, Ferah Tuncel, Zuhal Alt?ntas, Sema Erd |
Variation Analysis in Premenopausal and Postmenopausal Breast Cancer Cases. Journal of personalized medicine 2024 4 14 (4): . Ibrahim Halil Erdogdu, Seda Orenay-Boyacioglu, Olcay Boyacioglu, Duygu Gurel, Nurten Akdeniz, Ibrahim Meteog |
- Page last reviewed:Feb 1, 2024
- Content source: